Meitav Dash Investments LTD Galmed Pharmaceuticals Ltd. Transaction History

Meitav Dash Investments LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.62 - $7.11 $2.95 Million - $4.55 Million	-639,269 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$5.68 - $8.68 $81,343 - $124,306	-14,321 Reduced 2.19%	639,269 $4.69 Million
Q1 2019 May 13, 2019	SELL	$7.27 - $9.07 $559 - $698	-77 Reduced 0.01%	653,590 $5.34 Million
Q4 2018 Feb 13, 2019	SELL	$6.59 - $14.47 $1,911 - $4,196	-290 Reduced 0.04%	653,667 $4.47 Million
Q3 2018 Nov 14, 2018	BUY	$10.55 - $15.28 $1.88 Million - $2.72 Million	177,767 Added 37.33%	653,957 $8.95 Million

Q4 2017 Feb 15, 2018	BUY	$6.78 - $9.32 $3.23 Million - $4.44 Million	476,190	476,190 $4.36 Million

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $7.53M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.